These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23843413)

  • 1. Confusion after starting citalopram in a renal transplant patient.
    Sran H; Phanish MK
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23843413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citalopram-induced hyponatraemia and parkinsonism: potentially fatal side-effects not to be missed.
    Damali Amiri N; Wijenaike N
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25391825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First time, low dose citalopram use-related serotonin syndrome.
    Turedi S; Eraydin I; Gunduz A; Kalkan A; Hos U
    Neurotoxicology; 2007 Nov; 28(6):1272-4. PubMed ID: 18213744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram Induced SIADH in an Elderly Female: A Case Study.
    Vidyasagar S; Rao K; Verma M; Tripuraneni AD; Patil N; Bhattacharjee D
    Psychopharmacol Bull; 2017 Sep; 47(4):64-67. PubMed ID: 28936011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe symptomatic hyponatremia during citalopram therapy--a case report.
    Flores G; Perez-Patrigeon S; Cobos-Ayala C; Vergara J
    BMC Nephrol; 2004 Jan; 5():2. PubMed ID: 14728721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate antidiuretic hormone secretion and rhabdomyolysis associated with citalopram.
    Zullino D; Brauchli S; Horvath A; Baumann P
    Therapie; 2000; 55(5):651-2. PubMed ID: 11201982
    [No Abstract]   [Full Text] [Related]  

  • 8. Citalopram-induced SIADH in a hypertensive patient on salt restricted diet.
    Bez Y; Aktolga S; Balci M; Nurmedov S; Topçuoglu V
    J Psychopharmacol; 2007 Aug; 21(6):665-7. PubMed ID: 17092960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An isolated fever associated with selective serotonin reuptake inhibitors therapy.
    Benhamou Y; Leclair C; Cailleux N; Chauffrey I; Levesque H
    Intern Med J; 2009 Dec; 39(12):e4-5. PubMed ID: 20233235
    [No Abstract]   [Full Text] [Related]  

  • 11. Panic attacks associated with citalopram.
    Brauer HR; Nowicki PW; Catalano G; Catalano MC
    South Med J; 2002 Sep; 95(9):1088-9. PubMed ID: 12356120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical manifestation of confusion and hallucinations caused by an interaction between rasagiline and escitalopram].
    Bandrés Liso AC; Toyas Miazza C
    Farm Hosp; 2009; 33(3):173-5. PubMed ID: 19712602
    [No Abstract]   [Full Text] [Related]  

  • 14. [Galactorrhoea and the use of selective serotonin reuptake inhibitors].
    Wessels-van Middendorp AM; Timmerman L
    Tijdschr Psychiatr; 2006; 48(3):229-34. PubMed ID: 16956087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.
    Gougoulaki M; Lewis G; Nutt DJ; Peters TJ; Wiles NJ; Lewis G
    J Psychopharmacol; 2021 Aug; 35(8):919-927. PubMed ID: 33637001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram-induced subacute cutaneous lupus erythematosus -- first case and review concerning photosensitivity in selective serotonin reuptake inhibitors.
    Röhrs S; Geiser F; Conrad R
    Gen Hosp Psychiatry; 2012; 34(5):541-5. PubMed ID: 22534401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
    Näslund J; Hieronymus F; Emilsson JF; Lisinski A; Nilsson S; Eriksson E
    Acta Psychiatr Scand; 2017 Oct; 136(4):343-351. PubMed ID: 28859218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe symptomatic hyponatremia during citalopram therapy.
    Odeh M; Beny A; Oliven A
    Am J Med Sci; 2001 Feb; 321(2):159-60. PubMed ID: 11217819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
    Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A
    CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
    Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
    Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.